Digital Therapeutics Market by Application by Care, Sales Channel, B2B
According to the new market research report " Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021", published by MarketsandMarkets™, The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724
> The factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics.
Some of The Major Players In Digital Therapeutics Market :
- Proteus Digital Health, Inc. (U.S.)
- Omada Health Inc. (U.S.)
- WellDoc Inc. (U.S.)
- Livongo Health (U.S.)
- Noom Inc. (U.S.)
- Ginger.io Inc. (U.S.)
- Propeller Health (U.S.)
- 2Morrow Inc. (U.S.)
- Canary Health Inc. (U.S.), and Mango Health, Inc. (U.S.).
Get Sample Copy of This Report
@https://www.marketsandmarkets.com/requestsampleNew.asp?id=51646724
The factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics. However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.
Browse and in-depth TOC on "Digital Therapeutics Market"
148 - Tables
186 - Pages
36 - Figures
Digital Therapeutics Market segmented into :
> Based on sales channel, the digital therapeutics market is segmented into business to customer (B2C) and business to business (B2B).
> 2B segment is estimated to account for the largest share along with the highest CAGR of the digital therapeutics market.
> There is a growing inclination of pharmaceutical companies to integrate digital therapeutics with their drug product to offer adherence services along with their product. These are some of the factors responsible for the high share of this market segment.
Want Full Report? Inquire Here: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=145607690
The trisomy applications segment accounted for the largest share of the global NIPT market in 2018.
Based on application, the non-invasive prenatal testing (NIPT) market is segmented into trisomy, microdeletion syndrome, and other applications (gender identification and the detection of monogenic disorders, Klinefelter syndrome, and Rhesus (Rh) blood type). In 2018, trisomy was the largest application segment of the NIPT market. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can primarily be attributed to factors such as the increasing maternal age and the rising incidence of chromosomal abnormalities.
The diagnostic laboratories segment accounted for the largest share of the NIPT products market in 2018.Based on end user, the NIPT products market is classified into diagnostic laboratories and hospitals. In 2019, diagnostic laboratories formed the largest and fastest-growing end users of NIPT products. This can primarily be attributed to factors such as the implementation of initiatives by diagnostic laboratories to provide safe and effective prenatal tests and rising incidence of chromosomal abnormalities.